Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

Clinical trial NCT00268346 · COMPLETED

Trial details

NCT number: NCT00268346
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Esophageal Cancer

Start date: 2005-10-01
Primary completion: 2011-01-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.